Ongoing Payments Sample Clauses

Ongoing Payments. From the Termination Date until the earlier of: 4.6.1 the payment by the Scottish Ministers of any sum due as a lump sum pursuant to paragraph 4.1; and 4.6.2 the last Instalment Date, (a) for the preparation, audit (if required) and filing of all tax and information returns that are required to be filed by it in any jurisdiction in the period after the Termination Date (to the extent that such returns were not overdue as at the Termination Date); (b) in order to maintain the listing for the Bonds on the Official List maintained by the Luxembourg Stock Exchange or such other recognised stock exchange as defined in Section 1005 of the Income Tax Act 2007 and the admission to trading of the Bonds by the Luxembourg Stock Exchange or such other recognised stock exchange as defined in Section 1005 of the Income Tax Act 2007 in the period after the Termination Date; (c) for furnishing to the Luxembourg Stock Exchange such information as the Luxembourg Stock Exchange may be required to be furnished to it in the period after the Termination Date; (d) in respect of fees, costs or expenses (if any) payable by it to EIB (as defined in the Common Terms Agreement), the Bond Trustee (as defined in the Common Terms Agreement), the Principal Paying Agent (as defined in the Common Terms Agreement), the Monitoring Adviser (as defined in the Common Terms Agreement), the Intercreditor Agent, the Security Trustee, any receiver acting as trustee or receiver under the Senior Financing Agreements, the Account Bank (as defined in the Common Terms Agreement), any bond custodian and/or any rating agencies in each case as contemplated by the Senior Financing Agreements; (e) in connection with the corporate management, operation and administration of the Company, Holdco of the Issuer; and (f) in respect of any legal or other adviser fees incurred in connection with any of the above, any such costs and expenses to be reasonably and properly incurred (and, in the case of (b),

Ongoing Payments. The Reinsured shall credit the Reinsurer with its share of all premiums and shall debit the Reinsurer with its share of all losses, allowances and loss adjustment expenses paid by the Reinsured under the Underlying Policies for the business reinsured under this Agreement.

Ongoing Payments. Starting on January 15, 2020, the Purchaser shall issue to the D▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇ Revocable Trust the Ongoing Purchaser Stock Consideration. The Ongoing Purchaser Stock Consideration shall be paid as a Collateral Fee for the funds currently held by the Company bank account(s).

Ongoing Payments. While Executive is employed pursuant to this Agreement, AVC will pay Executive a salary at a rate of One Hundred and Fifteen Thousand Dollars ($115,000) per annum, payable in substantially equal monthly or more frequent installments.

Ongoing Payments. To the extent that FAFLIC receives monies, checks, drafts, money orders or other instruments payable to, or to the order of, FAFLIC and allocable to FAFLIC's general account from any third party relating to the Contracts, FAFLIC shall transfer such amounts to the Reinsurer no later than on the date the Monthly Statements are due. If applicable, FAFLIC shall pay such amounts, together with simple interest thereon from, and including, the earliest Monthly Statement on which such amounts could have been recorded to, but not including, the date of payment computed at an annual rate equal to the LIBOR rate.

Ongoing Payments. Fixed payments sized and to be * of payments made under the equipment lease. Contingent payments to be sized and equal to * of payments made under the equipment lease.

Ongoing Payments. During the term of the Option Period (as defined in Section 3.1 below) and prior to the exercise of the Option, the Grantee shall, with the reasonable assistance of the Stockholder, pay all of the Company’s expenses associated with the preparation and filing of its periodic reports with the Securities and Exchange Commission, including reasonable fees of the Company’s auditors, accountants and attorneys. In addition, the Grantee shall: (i) make monthly payments on the Company’s credit card in an amount not to exceed $600 per month, which credit card debt shall be fully paid by the Grantee on or before the date of exercise of the Option; and (ii) pay up to $200 per month in reasonable operating expenses of the Company.

Ongoing Payments. Tutti i pagamenti per le visite da effettuarsi sui soggetti partecipanti allo Studio, come indicato nella Tabella 1 sottostante, saranno corrisposti su base trimestrale per il numero effettivo di visite dello Studio completate dai soggetti partecipanti allo Studio adeguatamente arruolati (fermo restando che le CRF siano state compilate e presentate tramite il sistema elettronico di acquisizione dati), meno il venti percento (20%) di ciascun pagamento trimestrale, che sarà trattenuto fino al pagamento finale, quando sarà corrisposto. I pagamenti trimestrali saranno eseguiti entro quarantacinque (45) giorni dalla fine di ciascun trimestre. La periodicità trimestrale potrebbe non coincidere con il trimestre solare. Nessun pagamento sarà dovuto o effettuato per i soggetti arruolati nello Studio che non hanno soddisfatto i criteri di inclusione/esclusione del Protocollo a meno che non sia stata ottenuta dallo Sponsor la previa approvazione scritta per l’arruolamento di tale soggetto. Payments for completed Study subject visits, as set forth in Table 1 below, will be paid on a quarterly basis for the actual number of Study visits completed by properly enrolled Study subjects (provided that CRFs have been completed and submitted through the electronic data capture system), less twenty percent (20%) of each quarterly payment, which will be withheld until and paid with the final payment. Quarterly payments will be made within forty-five (45) days after the end of each quarter. The quarterly schedule may be offset from the calendar quarter. No payments will be owed or made for subjects enrolled in the Study who did not meet the Protocol inclusion/exclusion criteria unless prior written approval for the enrollment of such subject was obtained from the Sponsor.

Ongoing Payments. Subject to receipt of all Regulatory Approvals necessary to commercialize the Product, and to IntelGenx not abandoning its Product commercialization efforts, ongoing payments will be made to ▇▇▇▇, by IntelGenx or its Affiliate, as follows: (a) Subject to Section 4.5(b), (c), and (d) below, IntelGenx will pay ▇▇▇▇ (i) ten percent (10%) of all Net Product Sales relating to the Product and (ii) three percent (3%) of all Upfront Payments. Such payments to ▇▇▇▇ will be made by IntelGenx or its affiliate within 30 days of receipt by IntelGenx. (b) No payments will be due under this Section 4.5 or otherwise on any Products sold or transferred to customers as samples or for demonstration purposes. (c) Payments due under this Section 4.5 will continue until the earlier of: (i) all claims in all patents relating to the Product NDA, hereafter owned exclusively by IntelGenx, have expired or been determined to be invalid or (ii) the end of the commercial life of the Product in the Territory. The Parties expressly agree that the commercial life of the Product in the Territory excludes any improvements or amendments to the Product subsequent to the receipt of the NDA, including receipt of any additional Regulatory Approvals. (d) Once due, IntelGenx shall deduct from and against the Ongoing Payments otherwise due to ▇▇▇▇ under this Section 4.5, the sum of $200,000 which represents amounts previously paid by IntelGenx to ▇▇▇▇.